Prospective comparison of two flow cytometry methodologies for monitoring minimal residual disease in a multicenter treatment protocol of childhood acute lymphoblastic leukemia.

Source:http://linkedlifedata.com/resource/pubmed/id/20632326

Download in:

View as

General Info

PMID
20632326